ERBB2 and breast cancer: A retrospective study analyzing clinical records of 2193 breast cancer patients in Caro Oncology Center database, revealed that age less than 60 years, larger tumors, LN positivity, high tumor grade, and HER2 positivity were associated with a higher incidence of brain metastasis.15